A new uBiome Result

A reader asked me to look at the results they just got back. I was pleasantly surprise to see some significant improvements in their report

Lactobacillus and Bifidobacterium is now reported

bif

This is a classic CFS profile!

Akkermansia is cleanly reported

akk

Again, a classic CFS result. See this post on Increasing Akkermansia I did earlier.

Rare Bacteria are listed simply

rare

Checking a few other uBiome results that I could access, we did find a strong pattern for three. And an over representation (25% of the CFS samples versus 13% of general samples)

  • Thermonaerobacterales 2/8
  • Gelria:  2/8
  • Synergistaceae: 2/7
  • Low Akkermansia 6/8
  • Low Lactobacillus 8/8
  • Low Bifidobaceria 7/8

One reader was very rich in rare results:

veryRare

Bottom Line

Three groups appear to be very common as low to non-existent

  • Akkermansia  75%
  • Lactobacillus 100%
  • Bifidobaceria 87%

There is work going on in getting an Akkemansia probiotic approved for sale. Remember to avoid most lactobacillus because it will push out bifidobacteria… instead, focus on only bifidobacteria probiotics.

Metabolism Reports

Another new set of reports have been added, as shown below. This is done using data derived from the KEGG Pathway Database,

Mata

Each of these can expand, for example:

lipid

We see two items of interest, ALA (alpha-linolenic acid metabolism) is low and Arachidonic acid metabolism is high. See ALA article and Arachidonic acid metabolism: role in inflammation (1991)

  • So, taking ALA supplements would be strongly suggested

Spot checking other ubiome results, I saw one reader had

  • D-arginine and D-ornithine metabolism being a very low 0.09x
  • Flavonoid biosynthesis a low 0.27x

Again, this hits at specific supplements in lieu of gut bacteria doing their jobs.

Bottom Line 2

The ubiome results give much more friendly data and at a low cost. If you are unsure that you have CFS/IBS/FM, then comparing your results to the above may answer the question. Of greater interest is the additional tables of what part of the KEGG pathway may suggest supplementation.